Jazz Pharmaceuticals Plc (JAZZ) announced on Tuesday that its Jazz Investments I Ltd. intends to offer $850 million of senior notes due 2030 in a private offering.
Jazz also expects to grant the initial purchasers of the notes an option to purchase up to an additional $150 million of notes.
The drug maker expects to use a portion of the net proceeds to prepay up to around $350 million of the term loans and for general corporate purposes.
Jazz also aims to repurchase up to $150 million of its shares from purchasers of the notes in privately negotiated transactions.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.